Pacific Biosciences of California, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2021
Total Assets: $2.01B
Liabilities Breakdown FY2021
Total Liabilities: $1.22B
Asset Breakdown
Total Assets: $2.01B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $460.7M | 23.0% |
| Accounts Receivable | $24.2M | 1.2% |
| Inventory | $24.6M | 1.2% |
| Property, Plant & Equipment | $32.5M | 1.6% |
| Goodwill | $410.0M | 20.4% |
| Intangible Assets | $411.0M | 20.5% |
| Other Assets | $643.9M | 32.1% |
Liabilities Breakdown
Total Liabilities: $1.22B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $11.0M | 0.9% |
| Long-Term Debt | $896.1M | 73.7% |
| Other Liabilities | $308.9M | 25.4% |